Browser does not support script.
Birmingham has been at the forefront of transplants since the pioneering work of Sir Peter Medawar. Our researchers are continuing his legacy.
Developing the use of sensors and clocks in innovative, ground-breaking technologies to change the future landscapes of healthcare, transport, defence, civil engineering and more.
Academia partnering with business, investigating, developing and co-creating robust and innovative solutions to achieve responsible business success. Building the foundations for a more responsible and sustainable future.
We are working with partners across the globe to understand how to save lives at risk from poor air quality.
Challenging established views and policy responses to migration and its impact on societies in a rapidly changing world.
Birmingham academics work on major issues in international ethics and global justice and train the next generation of students to tackle these issues.
We explore what it means to be human – in historical and cultural contexts, within ethical and legal norms and through languages and communication.
From atoms to astronomy, computers to cars and robots to robust materials, our goal is to transform our understanding of the world to make life easier, healthier and more sustainable.
Across the breadth of life and environmental sciences we discover, apply and translate science, forging major advances in human and environmental health.
With over 1,000 academic staff researchers and around £80 million new research funding per year, we are dedicated to performing world-leading research with the ultimate goal of improving human health.
We address the challenges facing society and the economy, from shedding light on the refugee crisis, to character education in schools, through to developing leaders in the NHS.
We make a powerful contribution to understanding how genetic abnormalities within cancer cells lead to disease. Through Birmingham’s Cancer Research UK Clinical Trials Unit- one of Europe’s leading clinical trials unit- we use this information to design and rigorously assess new and proven cancer treatments. In so doing, we will play a significant role in accelerating the ultimate control of cancer.
Sudha Sundar has been elected as the first female president of the British Gynaecological Society
Experts identify key points in the cell where different DNA mutations drive leukaemia
Professor Ulrich Gunther succeeded in his bid for a 1 GHz NMR spectrometer
Scientists win award to tackle hard to treat cancers
Life Sciences in Six - Dr Joanna Parish
My story: Graham Silk
Posted 19 February 2019
Professor Sean Kehoe, Lawson Tait Professor of Gynaecological Cancer, writes on why identifying different approaches and challenging the accepted treatment strategies for patients with ovarian cancer is important.
Posted 13 February 2019
Mr Aneel Bhangu has been awarded a prestigious NIHR Clinician Scientist in Global Surgery Fellowship which will support the development of major surgical research trials in low and middle income countries
Posted 04 February 2019
New research carried out in collaboration with the University of Birmingham has found that giving young babies a general anaesthetic has no lasting impact on their brain development or behaviour.
View all news